Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sutro Biopharma, Inc. - Common Stock (NQ:STRO)

0.8952 -0.0148 (-1.63%)
Streaming Delayed Price Updated: 12:51 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sutro Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews
 
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Top stock movements in today's session.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Expert Outlook: Sutro Biopharma Through The Eyes Of 6 Analysts
 
Via Benzinga
A Glimpse Into The Expert Outlook On Sutro Biopharma Through 5 Analysts
 
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
Which stocks are moving on Monday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Peeling Back The Layers: Exploring Sutro Biopharma Through Analyst Insights
 
Via Benzinga
Analyst Expectations For Sutro Biopharma's Future
 
Via Benzinga
Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
 
Via Benzinga
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, March 15
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of March 10-14, 2025. 
Via Talk Markets
Topics Stocks / Equities
Top movers analysis one hour before the close of the markets on 2025-03-14: top gainers and losers in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Which stocks are experiencing notable movement on Friday?
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline
Sutro Biopharma reported $62 million in 2024 revenue, down from $153.7 million in 2023, and announced a pipeline restructuring. 
Via Benzinga
Dow Jumps Over 600 Points; US Consumer Sentiment Tumbles In March
 
Via Benzinga
Topics Stocks
Nasdaq Surges 1.5%; Ulta Beauty Posts Upbeat Results
 
Via Benzinga
This T-Mobile Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q2 2024
STRO stock results show that Sutro Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
STRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024
STRO stock results show that Sutro Biopharma missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.